Latest News - IQVIA
Top Corporates Hub
IQVIA
Waste Connections Stock Slides 7% Since Q4 Earnings Beat Estimates
17.02.2026 16:46
WCN shares fall 7% since fourth-quarter 2025 earnings topped estimates, as margin pressure, an operating loss and weaker recycling results weigh on sentiment.
Thursday's session: gap up and gap down stock in the S&P500 index
12.02.2026 15:35
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Earnings growth of 3.6% over 3 years hasn't been enough to translate into positive returns for IQVIA Holdings (NYSE:IQV) shareholders
12.02.2026 11:00
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
The Top 5 Analyst Questions From IQVIA’s Q4 Earnings Call
12.02.2026 05:36
IQVIA’s fourth quarter was marked by solid top-line growth, surpassing Wall Street’s revenue expectations. However, the market reacted negatively, focusing on margin compression and concerns about the sustainability of recent gains. Management attributed the quarter’s performance to continued investments in clinical and commercial offerings, expansion of Phase I trial capabilities, and strong demand for its data-as-a-service solutions. CEO Ari Bousbib acknowledged that a challenging macroeconomi
Oakmark Global All Cap Strategy Q4 2025 Performance Review
12.02.2026 05:07
Oakmark Global All Cap Strategy portfolio's return was 4.99% (net) for the reporting period vs. MSCI World Index that returned 3.12% for the same period. Read more here.
What Moved Markets This Week
07.02.2026 07:24
Weekly stock market update: Dow hits 50,000 as tech sells off; Bitcoin volatility, jobs data and top stock calls.
IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis
06.02.2026 05:35
Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue guidance of $17.25 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $3.42 per share was 0.7% above analysts’ consensus estimates.
IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings
04.02.2026 03:14
Clinical research company IQVIA (NYSE: IQV) will be reporting results this Thursday before market hours. Here’s what you need to know.
A Closer Look At IQVIA Holdings Inc.'s (NYSE:IQV) Impressive ROE
02.02.2026 12:00
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration
29.01.2026 13:00
RESEARCH TRIANGLE PARK, N.C., January 29, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic long-term collaboration with Boehringer Ingelheim. Boehringer Ingelheim has selected IQVIA’s Data-as-a-Service (DaaS+) technology offering as the accelerator to power its global commercial data harmonization and transformation journey.
What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing?
27.01.2026 13:00
IQVIA Holdings Inc. ( NYSE:IQV ) saw a decent share price growth of 14% on the NYSE over the last few months. The...
Estimating The Intrinsic Value Of IQVIA Holdings Inc. (NYSE:IQV)
22.01.2026 12:01
Key Insights IQVIA Holdings' estimated fair value is US$276 based on 2 Stage Free Cash Flow to Equity Current share...
XPH: Healthcare Dashboard For January
16.01.2026 12:21
The State Street SPDR S&P Pharmaceuticals ETF provides equal-weight exposure and cuts single-stock risk. Click here to read my latest analysis of XPH.
Is It Time To Reassess IQVIA (IQV) After A 22% One Year Share Price Gain
14.01.2026 07:09
If you are wondering whether IQVIA Holdings is fairly priced or if there is still room for value, this article walks you through what the current share price might be implying. The stock last closed at US$241.57, with returns of 0.4% over 7 days, 8.7% over 30 days, 7.2% year to date and 22.0% over the past year, which may have shifted how the market sees its risk and opportunity. Recent attention on IQVIA has centered on its role as a large player in contract research and real world data...
2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down
13.01.2026 04:36
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
The 24% return delivered to IQVIA Holdings' (NYSE:IQV) shareholders actually lagged YoY earnings growth
06.01.2026 12:00
The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 27% Discount?
23.12.2025 12:00
Key Insights The projected fair value for IQVIA Holdings is US$309 based on 2 Stage Free Cash Flow to Equity IQVIA...
IQVIA: Increasingly Indispensable In Drug Development
11.12.2025 13:56
Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock upside.
Those who invested in IQVIA Holdings (NYSE:IQV) five years ago are up 34%
05.12.2025 12:00
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...
Is IQVIA Holdings Stock Outperforming the S&P 500?
04.12.2025 03:32
IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly bullish on the stock’s prospects.